As we heard at this year’s World EPA Congress, now, more than ever, the Market Access and Pricing function is an important bridge between R&D, medical and commercial functions. It’s providing the foundation for clarity in label, evidence expectations, willingness to pay and market needs, all while communicating and “connecting the dots” between pharma’s other functions. 

Among the many plates to spin, analogues need to be considered at every stage, so that influencing drivers for price and market access can be evaluated. With all this in mind, working smarter, faster and making better decisions has never been so important.

In this webinar recorded on 18th May 2023, Founding Director Shri Rao Mukku explores analogue analysis dos and don’ts, uncovering the common mistakes they see in industry and how to avoid them.

Interviewed by Louise, Shri discusses:

• Key trends and changes in analogue analysis
• The biggest challenges early market access teams face when finding the right analogues
• How to take a systematic, rapid and repeatable approach to identifying and analysing analogues.

To learn more, complete the form below to receive a link to the recording.